WallStSmart
GRAL

GRAIL, LLC

NASDAQ: GRAL · HEALTHCARE · DIAGNOSTICS & RESEARCH

$61.64
-2.03% today

Updated 2026-05-08

Market cap
$2.69B
P/E ratio
P/S ratio
18.30x
EPS (TTM)
$-10.30
Dividend yield
52W range
$30 – $119
Volume
0.9M

WallStSmart proprietary scores

36
out of 100
Grade: D
Sell
Investment rating
6.7
Growth
B
4.8
Quality
C
2.0
Profitability
F
5.0
Valuation
C+
2/9
Piotroski F-Score
Weak
Altman Z-Score
Industry rank
View all highly rated stocks (75+) →195 stocks currently score above 75

Price targets

Analyst target
$67.71
+9.85%
12-Month target
Intrinsic (DCF)
Margin of safety
0 Strong Buy4 Buy4 Hold0 Sell0 Strong Sell

Price chart

Stock snapshot

Strengths
+ Revenue growth 14.00% QoQ
Risks
- Piotroski 2/9 — weak financial health
- Thin margins at -277.50%
- Negative free cash flow $-64.60M

Key financials

Revenue Net Income Free Cash Flow
Metric2022202320242025TTM
Revenue$55.55M$93.11M$125.59M$147.17M$147.17M
Net income$-5.40B$-1.47B$-2.03B$-408.35M$-93.19M
EPS$-10.30
Free cash flow$-584.17M$-608.69M$-582.36M$-299.92M$-64.60M
Profit margin-9,719.35%-1,574.23%-1,613.92%-277.47%-277.50%

Peer comparison

CompanyMkt CapScoreGrowthProfitValueQualityMoSRating
GRAL$2.69B366.72.05.04.8Hold
LLY$869.41B7810.010.05.06.5Strong Buy
JNJ$535.63B594.79.03.36.0-38.45%Buy
ABBV$358.55B634.08.04.05.0-20.52%Buy
UNH$335.78B545.35.57.34.8+42.20%Buy
AZN$286.68B626.08.55.35.0+6.60%Buy

Smart narrative

GRAIL, LLC trades at $61.64. Our Smart Value Score of 36/100 indicates the stock is weak. The company scores 2/9 on the Piotroski F-Score. TTM revenue stands at $147.17M. with profit margins at -277.50%.

Frequently asked questions

What is GRAIL, LLC's stock price?
GRAIL, LLC (GRAL) trades at $61.64.
Is GRAIL, LLC overvalued?
Smart Value Score 36/100 (Grade D, Sell).
What is the price target of GRAIL, LLC (GRAL)?
The analyst target price is $67.71, representing +9.8% upside from the current price of $61.64.
What is GRAIL, LLC's revenue?
TTM revenue is $147.17M.
Piotroski F-Score?
2/9 — weak financial health.

Company info

SectorHEALTHCARE
IndustryDIAGNOSTICS & RESEARCH
CountryUSA
ExchangeNASDAQ
CurrencyUSD

Quick metrics

P/S ratio18.30x
ROE-16.10%
Beta
50D MA$50.88
200D MA$67.11
Shares out0.04B
Float0.03B
Short ratio
Avg volume0.9M

Performance

1 week
1 month
3 months
YTD
1 year
3 years
5 years